Shanghai Rongtai Health Technology Corporation Limited (603579.SS)
CNY 15.21
(-0.33%)
CNY 15.21
(-0.33%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 317.55 Million CNY | 7.44% |
| 2022 | 281.3 Million CNY | -24.08% |
| 2021 | 357.21 Million CNY | 44.3% |
| 2020 | 252.15 Million CNY | -27.27% |
| 2019 | 411.79 Million CNY | -6.26% |
| 2018 | 383.2 Million CNY | 24.44% |
| 2017 | 316.76 Million CNY | 19.52% |
| 2016 | 274.7 Million CNY | 48.69% |
| 2015 | 197.18 Million CNY | 105.14% |
| 2014 | 81.63 Million CNY | 153.74% |
| 2013 | 34.6 Million CNY | 203.9% |
| 2012 | 7.51 Million CNY | -54.04% |
| 2011 | 24.5 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 49.21 Million CNY | -23.63% |
| 2024 Q1 | 68.08 Million CNY | 9.73% |
| 2024 Q3 | 31.04 Million CNY | -51.91% |
| 2023 Q3 | 63.79 Million CNY | -25.86% |
| 2023 Q4 | 54.86 Million CNY | -13.99% |
| 2023 FY | - CNY | 7.44% |
| 2023 Q1 | 54.97 Million CNY | -19.87% |
| 2023 Q2 | 86.04 Million CNY | 56.52% |
| 2022 FY | - CNY | -24.08% |
| 2022 Q3 | 51.93 Million CNY | 25.06% |
| 2022 Q2 | 41.52 Million CNY | -45.72% |
| 2022 Q1 | 76.5 Million CNY | -2.82% |
| 2022 Q4 | 68.6 Million CNY | 32.1% |
| 2021 Q3 | 68.19 Million CNY | -24.16% |
| 2021 Q1 | 92.2 Million CNY | 142.54% |
| 2021 Q2 | 89.92 Million CNY | -2.47% |
| 2021 FY | - CNY | 44.3% |
| 2021 Q4 | 78.72 Million CNY | 15.44% |
| 2020 Q1 | 35.73 Million CNY | -70.55% |
| 2020 FY | - CNY | -27.27% |
| 2020 Q2 | 83.67 Million CNY | 134.14% |
| 2020 Q4 | 38.01 Million CNY | -42.0% |
| 2020 Q3 | 65.54 Million CNY | -21.67% |
| 2019 Q1 | 48.34 Million CNY | 50.0% |
| 2019 FY | - CNY | -6.26% |
| 2019 Q4 | 121.35 Million CNY | 77.85% |
| 2019 Q3 | 68.23 Million CNY | -19.32% |
| 2019 Q2 | 84.57 Million CNY | 74.92% |
| 2018 Q4 | 32.23 Million CNY | -62.3% |
| 2018 Q2 | 78.59 Million CNY | -17.81% |
| 2018 Q1 | 95.63 Million CNY | 88.42% |
| 2018 FY | - CNY | 24.44% |
| 2018 Q3 | 85.5 Million CNY | 8.79% |
| 2017 Q2 | 66.02 Million CNY | -10.48% |
| 2017 Q3 | 70.28 Million CNY | 6.45% |
| 2017 FY | - CNY | 19.52% |
| 2017 Q1 | 73.75 Million CNY | -22.89% |
| 2017 Q4 | 50.75 Million CNY | -27.78% |
| 2016 Q1 | 58.23 Million CNY | -24.3% |
| 2016 FY | - CNY | 48.69% |
| 2016 Q3 | 42.66 Million CNY | -28.78% |
| 2016 Q4 | 95.64 Million CNY | 124.2% |
| 2016 Q2 | 59.89 Million CNY | 2.86% |
| 2015 Q4 | 76.93 Million CNY | 0.0% |
| 2015 FY | - CNY | 105.14% |
| 2014 FY | - CNY | 153.74% |
| 2014 Q2 | 18.47 Million CNY | 0.0% |
| 2014 Q1 | 18.47 Million CNY | 0.0% |
| 2013 FY | - CNY | 203.9% |
| 2012 FY | - CNY | -54.04% |
| 2011 FY | - CNY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Phenix Optical Company Limited | 72.86 Million CNY | -335.795% |
| China United Travel Co.,Ltd | 11.5 Million CNY | -2661.001% |
| Dalian Sunasia Tourism Holding CO.,LTD | 183.62 Million CNY | -72.937% |
| Shanghai Phoenix Enterprise (Group) Co., Ltd. | 160.17 Million CNY | -98.259% |
| Zhonglu.Co.,Ltd | 65.18 Million CNY | -387.175% |
| BanBao Co., Ltd. | 152.44 Million CNY | -108.305% |
| Zhejiang Natural Outdoor Goods Inc. | 191.64 Million CNY | -65.698% |
| Shuhua Sports Co., Ltd. | 241.32 Million CNY | -31.589% |
| Fujian Forecam Optics Co., Ltd. | 31.66 Million CNY | -902.854% |